About 10% of the population in western countries suffer from abdominal pain and change of bowel habits - known as the irritable bowel syndrome. The patients suffer from low quality of life and they are often not well taken care of within the public healthcare system. They often feel frustrated and seek both their family doctors, specialists and alternative medicine for help. Many patients feel they do not know enough about their disease, and the uncertainty may enhance bowel symptoms. We want to evaluate the effect of patient information and education in these patients.

Evaluation of further patient needs after education [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Enrollment:

200

Study Start Date:

January 2006

Study Completion Date:

January 2008

Primary Completion Date:

January 2008 (Final data collection date for primary outcome measure)

Intervention Details:

Behavioral: patient education

Patient education group

Detailed Description:

The patients are enrolled in endoscopic clinics in 7 hospitals in Norway. They are randomized to receive intervention now (intervention group) or in 6 months (control group). The intervention is a 6 hour education about the irritable bowel syndrome, held by a experienced gastroenterologist at the local hospital.

The patients are evaluated at time: 0 months and 6 months (intervention group and control group), 12 months (control group) and after 2 years (both groups).

Eligibility

Ages Eligible for Study:

18 Years to 70 Years

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

Yes

Criteria

Inclusion Criteria:

A diagnosis of Irritable Bowel Syndrome, verified by the Rome II criteria

Must be able to participate in a education-group

Exclusion Criteria:

Another GI-diagnosis or kind of surgery that may interfere with the symptoms of irritable bowel syndrome

Serious, untreated psychiatric disorder

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00305968